A higher apoptotic rate of DLBCL cells in the absence of stromal cells was noted as compared to when stromal cells were present (Figure S4), indicating that the ROR1 inhibitor could only partially overcome the tumor-promoting effects of stromal cells in this system. Here, ROR1 is linked to neoplasm.